-+ 0.00%
-+ 0.00%
-+ 0.00%

PROTAGONIST THERAPEUTICS, INC. : LEERINK PARTNERS ASSUMES COVERAGE WITH OUTPERFORM RATING; TARGET PRICE $190

路透·10/12/2026 10:09:36

請登錄查看新聞詳情